7254

543427

MEDPLUS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MEDPLUS HEALTH SERV LTD Share Price Today

MEDPLUS HEALTH SERV LTD is currently trading at ₹835, down by ₹6.95 from the previous close. The stock touched an intraday high of ₹856.60 and a low of ₹828.30 during the latest trading session. Over the past one year, MEDPLUS HEALTH SERV LTD has delivered a loss of 5.11%, while the stock has declined 6.13% in the last one month.

MEDPLUS HEALTH SERV LTD performance

Today’s low Today’s high
₹ 828.30 ₹ 856.60
₹ 835.00
52 week low 52 week high
₹ 732.00 ₹ 1022.20
₹ 835.00
Open Price ₹ 842.05
Prev. Close ₹ 841.95
Volume (Shares) 202137.00
Total traded value ₹ 1687.84
Upper Circuit ₹ 1010.30
Lower Circuit ₹ 673.60
info

Investment Returns

Over 1 Month -6.13% Over 3 Months 2.40% Over 6 Months 2.63% Over 1 Year -5.11%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDPLUS HEALTH SERV LTD fundamentals


  • Market cap (Cr) 10,031.40
  • P/E Ratio (TTM) 161.98
  • Beta 0.49
  • Book Value / share 109.55
  • Return on equity 3.11%
  • EPS (TTM) 5.20
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 16.67
info icon alternate text
  • Market cap (Cr) 10,075.90
  • P/E Ratio (TTM) 161.98
  • Beta 0.44
  • Book Value / share 109.55
  • Return on equity 3.11%
  • EPS (TTM) 5.20
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 16.67
info icon alternate text

MEDPLUS HEALTH SERV LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 248.04
Operating Expense 227.47
Net Profit 16.67
Net Profit Margin (%) 6.72
Earnings Per Share (EPS) 1.39
EBITDA 29.90
Effective Tax Rate (%) 27.66
Particulars DEC 2025 (Values in Cr)
Revenue 223.00
Operating Expense 203.88
Net Profit 16.58
Net Profit Margin (%) 7.43
Earnings Per Share (EPS) 1.38
EBITDA 31.41
Effective Tax Rate (%) 24.04
Particulars SEP 2025 (Values in Cr)
Revenue 205.65
Operating Expense 187.97
Net Profit 15.63
Net Profit Margin (%) 7.60
Earnings Per Share (EPS) 1.31
EBITDA 30.02
Effective Tax Rate (%) 24.16
Particulars JUN 2025 (Values in Cr)
Revenue 183.88
Operating Expense 168.85
Net Profit 13.53
Net Profit Margin (%) 7.35
Earnings Per Share (EPS) 1.13
EBITDA 26.54
Effective Tax Rate (%) 23.47
Particulars MAR 2025 (Values in Cr)
Revenue 201.75
Operating Expense 186.49
Net Profit 13.98
Net Profit Margin (%) 6.92
Earnings Per Share (EPS) 1.17
EBITDA 26.50
Effective Tax Rate (%) 21.94
Particulars MAR 2026 (Values in Cr)
Revenue 860.57
Operating Expense 788.16
Net Profit 62.41
Net Profit Margin (%) 7.25
Earnings Per Share (EPS) 5.21
EBITDA 117.87
Effective Tax Rate (%) 24.96
Particulars MAR 2025 (Values in Cr)
Revenue 713.10
Operating Expense 670.87
Net Profit 40.34
Net Profit Margin (%) 5.65
Earnings Per Share (EPS) 3.37
EBITDA 86.74
Effective Tax Rate (%) 21.18
Particulars MAR 2024 (Values in Cr)
Revenue 467.03
Operating Expense 467.40
Net Profit 9.44
Net Profit Margin (%) 2.02
Earnings Per Share (EPS) 0.79
EBITDA 39.48
Effective Tax Rate (%) -36.02
Particulars MAR 2023 (Values in Cr)
Revenue 213.93
Operating Expense 222.58
Net Profit 5.54
Net Profit Margin (%) 2.58
Earnings Per Share (EPS) 0.46
EBITDA 29.45
Effective Tax Rate (%) 26.87
Particulars MAR 2022 (Values in Cr)
Revenue 145.71
Operating Expense 149.68
Net Profit 5.58
Net Profit Margin (%) 3.82
Earnings Per Share (EPS) 0.50
EBITDA 12.84
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 145.42
ROE % 9.05
ROCE % 10.36
Total Debt to Total Equity 0.64
EBITDA Margin 8.73
Particulars MAR 2024 (Values in Cr)
Book Value / Share 132.01
ROE % 4.27
ROCE % 6.74
Total Debt to Total Equity 0.62
EBITDA Margin 7.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 124.99
ROE % 3.45
ROCE % 5.57
Total Debt to Total Equity 0.59
EBITDA Margin 6.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 118.84
ROE % 8.82
ROCE % 10.26
Total Debt to Total Equity 0.65
EBITDA Margin 8.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8030.09
ROE % 10.03
ROCE % 12.68
Total Debt to Total Equity 0.85
EBITDA Margin 7.76
Particulars MAR 2025 (Values in Cr)
Book Value / Share 103.63
ROE % 3.11
ROCE % 4.31
Total Debt to Total Equity 0.08
EBITDA Margin 11.20
Particulars MAR 2024 (Values in Cr)
Book Value / Share 99.36
ROE % 0.74
ROCE % 1.12
Total Debt to Total Equity 0.07
EBITDA Margin 7.82
Particulars MAR 2023 (Values in Cr)
Book Value / Share 95.66
ROE % 0.44
ROCE % 1.07
Total Debt to Total Equity 0.06
EBITDA Margin 13.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 93.28
ROE % 0.63
ROCE % 0.90
Total Debt to Total Equity 0.03
EBITDA Margin 8.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3273.97
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -9.78
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 367.21
Total Assets 3360.09
Total Liabilities 3360.09
Total Equity 1739.89
Share Outstanding 11
Price to Book Ratio 7.33
Return on Assets (%) 4.47
Return on Capital (%) 8.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 141.68
Total Assets 3004.80
Total Liabilities 3004.80
Total Equity 1577.35
Share Outstanding 11
Price to Book Ratio 6.94
Return on Assets (%) 2.17
Return on Capital (%) 4.15
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 283.83
Total Assets 2796.71
Total Liabilities 2796.71
Total Equity 1490.50
Share Outstanding 11
Price to Book Ratio 6.81
Return on Assets (%) 1.77
Return on Capital (%) 3.34
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 34.40
Total Assets 2594.04
Total Liabilities 2594.04
Total Equity 1417.25
Share Outstanding 11
Price to Book Ratio 10.83
Return on Assets (%) 3.69
Return on Capital (%) 6.14
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 118.59
Total Assets 1565.64
Total Liabilities 1565.64
Total Equity 731.10
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.07
Return on Capital (%) 7.37
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 57.02
Total Assets 1399.45
Total Liabilities 1399.45
Total Equity 1240.34
Share Outstanding 11
Price to Book Ratio 7.33
Return on Assets (%) 2.88
Return on Capital (%) 3.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 63.14
Total Assets 1309.98
Total Liabilities 1309.98
Total Equity 1187.65
Share Outstanding 11
Price to Book Ratio 6.94
Return on Assets (%) 0.72
Return on Capital (%) 0.79
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 90.16
Total Assets 1271.94
Total Liabilities 1271.94
Total Equity 1141.27
Share Outstanding 11
Price to Book Ratio 6.81
Return on Assets (%) 0.43
Return on Capital (%) 0.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 7.43
Total Assets 1187.45
Total Liabilities 1187.45
Total Equity 1112.78
Share Outstanding 11
Price to Book Ratio 10.83
Return on Assets (%) 0.46
Return on Capital (%) 0.5
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 86.67
Total Assets 548.42
Total Liabilities 548.42
Total Equity 517.48
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -1.56
Return on Capital (%) -1.66
Particulars MAR 2025 (Values in Cr)
Net Income 183.28
Cash from Operations 585.65
Cash from Investing -317.60
Cash from Financing -227.97
Net change in Cash -5.15
Free Cash Flow 645.10
Particulars MAR 2024 (Values in Cr)
Net Income 73.44
Cash from Operations 172.96
Cash from Investing -82.79
Cash from Financing -198.10
Net change in Cash -137.16
Free Cash Flow 257.35
Particulars MAR 2023 (Values in Cr)
Net Income 47.16
Cash from Operations 104.34
Cash from Investing 429.44
Cash from Financing -170.24
Net change in Cash 349.60
Free Cash Flow 273.34
Particulars MAR 2022 (Values in Cr)
Net Income 117.94
Cash from Operations 203.45
Cash from Investing -703.12
Cash from Financing 440.42
Net change in Cash -92.80
Free Cash Flow 321.17
Particulars MAR 2021 (Values in Cr)
Net Income 95.09
Cash from Operations 31.60
Cash from Investing -34.54
Cash from Financing -5.62
Net change in Cash -37.28
Free Cash Flow 85.86
Particulars MAR 2025 (Values in Cr)
Net Income 51.17
Cash from Operations 55.41
Cash from Investing -39.18
Cash from Financing -9.91
Net change in Cash -2.42
Free Cash Flow 64.64
Particulars MAR 2024 (Values in Cr)
Net Income 6.94
Cash from Operations 10.68
Cash from Investing -24.42
Cash from Financing -5.97
Net change in Cash -22.03
Free Cash Flow 23.07
Particulars MAR 2023 (Values in Cr)
Net Income 7.58
Cash from Operations 13.21
Cash from Investing 31.71
Cash from Financing -8.35
Net change in Cash 34.76
Free Cash Flow 74.95
Particulars MAR 2022 (Values in Cr)
Net Income 5.57
Cash from Operations -16.36
Cash from Investing -635.99
Cash from Financing 568.62
Net change in Cash -85.74
Free Cash Flow 24.26
Particulars MAR 2021 (Values in Cr)
Net Income -8.56
Cash from Operations -6.51
Cash from Investing -14.76
Cash from Financing 96.94
Net change in Cash 75.93
Free Cash Flow 5.96
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
TRENT LTD. 3246.35 100.29 24.78 173105.87 2184.08 4172.69
WARREN TEA LTD. 44.50 0.00 0.55 53.18 33.30 63.50
MULLER & PHIPPS (INDIA) LTD. 212.90 0.00 -6.41 13.31 188.10 377.00
Crysdale Industries Limited 13.23 0.00 0.56 2.18 0.00 0.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
TRENT LTD. 3246.35 96.39 22.47 173105.87 2184.08 4172.69
Saptak Chem And Business Limit 42.84 0.00 -28.82 13.17 3.20 64.13
WARREN TEA LTD. 44.50 0.00 0.62 53.18 33.30 63.50
MULLER & PHIPPS (INDIA) LTD. 212.90 0.00 -6.44 13.31 188.10 377.00

MEDPLUS HEALTH SERV LTD shareholding pattern

Holding
16.43%
40.21%
15.52%
27.81%
60.74%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MEDPLUS HEALTH SERV LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
835.00 -0.82 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 843.80
  • 26 Days 866.20
  • 10 Days 851.70
  • 50 Days 868.60
  • 12 Days 854.40
  • 100 Days 859.40
  • 20 Days 862.60
  • 200 Days 842.20
840.82 PIVOT
First Support 835.28 First Resistance 847.48 Second Support 828.62 Second Resistance 853.02 Third Support 823.08 Third Resistance 859.68
RSI 41.16 ADX 19.16 MACD -11.77 Williams % R -77.42 Commodity Channel Index (CCI) -112.69
Date 2026-06-24 Week 63760.00 Same Day 54809.00 Month 119323.00
1 Year 0.49 3 Year 0.46
Over 1 Month
-6.13% down
Over 1 Year
-5.11% down
Over 3 Months
2.40% down
Over 3 Years
2.88% down
Over 6 Months
2.63% down
Over 5 Years
-5.56% down

MEDPLUS HEALTH SERV LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medplus Health Services Ltd?

Answer Field

Medplus Health Services Ltd share price is for NSE ₹ 835.00 & for BSE ₹ 838.70 as on Jun 25 2026 03:30 PM.

What is the Market Cap of Medplus Health Services Ltd Share?

Answer Field

The market cap of Medplus Health Services Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 03:30 PM.

What is the 52 Week High and Low of Medplus Health Services Ltd?

Answer Field

The 52 Week High and Low of Medplus Health Services Ltd for NSE is ₹ 1,022.20 and ₹ 732.00 and for BSE is ₹ 1,020.35 and ₹ 731.95.

What is 1 year return for Medplus Health Services Ltd?

Answer Field

The 1 year returns on the stock has been -5.11%.

What is the P/E Ratio of Medplus Health Services Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM the price-to-earnings (PE) ratio for Medplus Health Services Ltd share is 161.98.

What is the PB ratio of Medplus Health Services Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM, the price-to-book (PB) ratio for Medplus Health Services Ltd share is 109.55.

How to Buy Medplus Health Services Ltd Share?

Answer Field

You can trade in Medplus Health Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medplus Health Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Medplus Health Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medplus Health Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|